Business Wire

UPS Unveils Game-Changing UPS ® Global Checkout: No More Surprise Import Fees

26.3.2025 15:30:00 EET | Business Wire | Press release

Share

UPS (NYSE:UPS) today announced the launch of UPS Global Checkout, an exciting new service that makes it even easier for consumers around the world to buy online from shippers around the world. Until now, international purchases often arrived with an unpleasant surprise – an additional bill for unpaid import costs. UPS Global Checkout solves that problem by guaranteeing upfront the amount online shoppers pay in duties, fees and taxes, and eliminating the frustration of unexpected costs at delivery.

UPS is the only global integrated carrier to offer a guaranteed landed cost solution for international shipping that is seamlessly incorporated into its shipping technology, transforming the shopping experience and offering complete transparency on costs. With updates in near real time, the service adjusts to policy changes, international tax laws, duties and tariffs, helping to avoid surprise costs and offering a positive delivery experience. Available in 43 origin countries and delivering to more than 200 destinations worldwide, the service helps businesses of all sizes grow globally by streamlining international shipping.

"With UPS Global Checkout, we’re making international shopping around the world as easy as buying in-store," said Kate Gutmann, EVP and president of International, Healthcare and Supply Chain Solutions at UPS. "Online shoppers can now enjoy full transparency and peace of mind with no surprises, knowing what they pay at checkout is the total cost for a cross-border purchase. This, combined with our total UPS premium delivery experience, benefits our customers – the retailers – by helping to drive additional sales. Given trade shifts around the world, expanding growth opportunities in new markets can now be seamless."

Customs duties, taxes and fees are a significant concern for international shoppers. Every day, tens of thousands of residential deliveries around the world arrive with duties and taxes payable on delivery. And a survey of U.S. and U.K. shoppers found 41% were deterred from buying from an international e-commerce site if the amount of duties and taxes was not crystal clear at checkout.

How UPS Global Checkout changes the game

Guaranteed total landed cost: Purchasers see the total cost, including duties, fees and taxes, before completing their purchase on eligible shipments.*

Enhanced customer experience: No surprise charges at delivery, leading to increased customer satisfaction and encouraging repeat purchases.

Data-driven accuracy: UPS Global Checkout uses artificial intelligence to assess items in the shopping cart and calculate the correct duties and taxes.

Peace of mind: Helps businesses more easily comply with international duties and tariffs.

UPS Global Checkout is one of several new tools UPS offers that simplify cross-border e-commerce. UPS Export Assure offers AI-powered assistance to create export documentation. And UPS Paperless® Invoice helps our customers save time, reduce errors and enhance sustainability by eliminating paper forms.

Learn more about how UPS is helping businesses to ship internationally.

*Terms and conditions apply.

About UPS

UPS (NYSE: UPS) is one of the world’s largest companies, with 2024 revenue of $91.1 billion, and provides a broad range of integrated logistics solutions for customers in more than 200 countries and territories. Focused on its purpose statement, “Moving our world forward by delivering what matters,” the company’s approximately 490,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. More information can be found at www.ups.com, about.ups.com and investors.ups.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250326480482/en/

Contacts

UPS Media Relations: pr@ups.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release

Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye